Today, we have to share some bad news about Organovo and its liver tissue bioprinting program. Present state and future steps Organovo, a biotechnology company currently valued at $45M and most well-known for researching bioprinting technologies – the creation of artificial organs – has recently announced that it is suspending its artificial liver tissue program…

Researchers in Cambridge have created a new approach for creating and transplanting artificial bile ducts with the aim of treating liver disease in children and reducing the need for transplants. The research, published in the journal Nature Medicine, shows how the researchers grew 3D cell structures and transplanted them into mice[1]. These structures then developed into…

© 2018 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

       Powered by MMD